{"entity":{"type":"insider","cik":"0001585160","url":"/insider/0001585160","json_url":"/insider/0001585160.json","name":"Landry Robert E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":291,"n_filings":36,"first":"2015-08-06","last":"2023-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Landry Robert E","source":"filing","n_filings":36,"first_seen":"2015-08-06","last_seen":"2023-08-25"}],"transactions":[{"id":8570967,"accession":"0001968202-23-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001968202-23-000030","line_url":"/filing/0001968202-23-000030#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":844.0,"price_display":"844.00","price_state":"stated","total_value":188212.0,"total_display":"188,212.00","total_whole":"188,212","shares_owned_after":31699.0,"shares_owned_after_display":"31,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider"},{"id":8595995,"accession":"0001968202-23-000004","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001968202-23-000004","line_url":"/filing/0001968202-23-000004","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1007.0,"shares_display":"1,007","price_per_share":823.468579940417,"price_display":"823.47","price_state":"stated","total_value":829232.86,"total_display":"829,232.86","total_whole":"829,233","shares_owned_after":31953.0,"shares_owned_after_display":"31,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-29","scope":"insider","n_lines":8},{"id":8595976,"accession":"0001968202-23-000004","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-23-000004","line_url":"/filing/0001968202-23-000004","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":183.0,"shares_display":"183","price_per_share":821.7043169398908,"price_display":"821.70","price_state":"stated","total_value":150371.89,"total_display":"150,371.89","total_whole":"150,372","shares_owned_after":33023.0,"shares_owned_after_display":"33,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider","n_lines":8},{"id":8050761,"accession":"0001883850-23-000035","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001883850-23-000035","line_url":"/filing/0001883850-23-000035","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":752.0,"shares_display":"752","price_per_share":788.8805319148936,"price_display":"788.88","price_state":"stated","total_value":593238.16,"total_display":"593,238.16","total_whole":"593,238","shares_owned_after":32693.0,"shares_owned_after_display":"32,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider","n_lines":14},{"id":8050706,"accession":"0001883850-23-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001883850-23-000035","line_url":"/filing/0001883850-23-000035#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":739.0,"shares_display":"739","price_per_share":764.5,"price_display":"764.50","price_state":"stated","total_value":564965.5,"total_display":"564,965.50","total_whole":"564,966","shares_owned_after":32105.0,"shares_owned_after_display":"32,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-07","scope":"insider"},{"id":6663546,"accession":"0001883850-22-000102","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001883850-22-000102","line_url":"/filing/0001883850-22-000102","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":610.0,"shares_display":"610","price_per_share":756.6617704918033,"price_display":"756.66","price_state":"stated","total_value":461563.68,"total_display":"461,563.68","total_whole":"461,564","shares_owned_after":28772.0,"shares_owned_after_display":"28,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-02","scope":"insider","n_lines":3},{"id":6232395,"accession":"0001883850-22-000086","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001883850-22-000086","line_url":"/filing/0001883850-22-000086","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":482.0,"shares_display":"482","price_per_share":758.063153526971,"price_display":"758.06","price_state":"stated","total_value":365386.44,"total_display":"365,386.44","total_whole":"365,386","shares_owned_after":28780.0,"shares_owned_after_display":"28,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider","n_lines":10},{"id":6530194,"accession":"0001883850-22-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001883850-22-000082","line_url":"/filing/0001883850-22-000082#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":739.5,"price_display":"739.50","price_state":"stated","total_value":264741.0,"total_display":"264,741.00","total_whole":"264,741","shares_owned_after":28744.0,"shares_owned_after_display":"28,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-18","scope":"insider"},{"id":6708318,"accession":"0001883850-22-000040","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001883850-22-000040","line_url":"/filing/0001883850-22-000040#line-25","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1226.0,"shares_display":"1,226","price_per_share":733.52,"price_display":"733.52","price_state":"stated","total_value":899295.52,"total_display":"899,295.52","total_whole":"899,296","shares_owned_after":29247.0,"shares_owned_after_display":"29,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider"},{"id":6708315,"accession":"0001883850-22-000040","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001883850-22-000040","line_url":"/filing/0001883850-22-000040#line-24","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":189.0,"shares_display":"189","price_per_share":736.61,"price_display":"736.61","price_state":"stated","total_value":139219.29,"total_display":"139,219.29","total_whole":"139,219","shares_owned_after":28834.0,"shares_owned_after_display":"28,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider"},{"id":6708312,"accession":"0001883850-22-000040","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001883850-22-000040","line_url":"/filing/0001883850-22-000040#line-23","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149.0,"shares_display":"149","price_per_share":735.36,"price_display":"735.36","price_state":"stated","total_value":109568.64,"total_display":"109,568.64","total_whole":"109,569","shares_owned_after":29023.0,"shares_owned_after_display":"29,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider"},{"id":6708310,"accession":"0001883850-22-000040","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001883850-22-000040","line_url":"/filing/0001883850-22-000040#line-22","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001585160","owner_name":"Landry Robert E","owner_display_name":"Landry Robert E","owner_url":"/insider/0001585160","role":"Officer (EVP Finance CFO)","role_mark":"O","role_mark_label":"Officer (EVP Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":734.53,"price_display":"734.53","price_state":"stated","total_value":55089.75,"total_display":"55,089.75","total_whole":"55,090","shares_owned_after":29172.0,"shares_owned_after_display":"29,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider"}],"collapsed":true,"next_cursor":"2022-04-11|6708310","ledger_fault":false,"count":{"value":291,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":291,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":291},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS, INC.","url":"/issuer/0000872589","role":"Officer (EVP Finance CFO)","n_filings":36,"first_seen":"2015-08-06","last_seen":"2023-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585160","retrieved_at":"2026-08-23T08:41:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}